State Street’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$156M Sell
559,570
-34
-0% -$9.79K 0.01% 1097
2025
Q4
$170M Sell
559,604
-11,995
-2% -$3.74M 0.01% 1039
2025
Q3
$160M Sell
571,599
-12,767
-2% -$3.47M 0.01% 1074
2025
Q2
$141M Sell
584,366
-110,154
-16% -$26M 0.01% 1121
2025
Q1
$169M Buy
694,520
+4,355
+0.6% +$1.31M 0.01% 984
2024
Q4
$227M Buy
690,165
+54,249
+9% +$18.4M 0.01% 859
2024
Q3
$213M Sell
635,916
-223,975
-26% -$71.1M 0.01% 886
2024
Q2
$235M Sell
859,891
-13,784
-2% -$4.01M 0.01% 773
2024
Q1
$302M Sell
873,675
-1,239
-0.1% -$407K 0.01% 677
2023
Q4
$283M Buy
874,914
+15,591
+2% +$4.89M 0.01% 681
2023
Q3
$308M Sell
859,323
-41,250
-5% -$15.9M 0.02% 595
2023
Q2
$341M Sell
900,573
-21,279
-2% -$8.66M 0.02% 596
2023
Q1
$442M Sell
921,852
-25,926
-3% -$12.1M 0.02% 522
2022
Q4
$399M Sell
947,778
-10,926
-1% -$4.41M 0.02% 537
2022
Q3
$400M Buy
958,704
+2,869
+0.3% +$1.43M 0.03% 525
2022
Q2
$473M Sell
955,835
-28,697
-3% -$14.9M 0.03% 494
2022
Q1
$555M Sell
984,532
-24,002
-2% -$14.5M 0.03% 502
2021
Q4
$762M Buy
1,008,534
+26,229
+3% +$19.6M 0.04% 433
2021
Q3
$733M Buy
982,305
+7,864
+0.8% +$5.89M 0.04% 422
2021
Q2
$628M Buy
974,441
+2,702
+0.3% +$1.64M 0.03% 467
2021
Q1
$555M Sell
971,739
-5,833
-0.6% -$3.45M 0.03% 472
2020
Q4
$570M Buy
977,572
+18,835
+2% +$10.7M 0.03% 441
2020
Q3
$494M Buy
958,737
+31,795
+3% +$16.1M 0.03% 432
2020
Q2
$419M Buy
926,942
+240,255
+35% +$106M 0.03% 473
2020
Q1
$241M Buy
686,687
+29,834
+5% +$11M 0.02% 551
2019
Q4
$243M Buy
656,853
+156,001
+31% +$55M 0.02% 654
2019
Q3
$167M Buy
500,852
+7,000
+1% +$2.28M 0.01% 743
2019
Q2
$154M Buy
493,852
+4,222
+0.9% +$1.26M 0.01% 783
2019
Q1
$150M Buy
489,630
+19,863
+4% +$5.36M 0.01% 779
2018
Q4
$109M Sell
469,767
-40,258
-8% -$10.8M 0.01% 857
2018
Q3
$160M Buy
510,025
+3,367
+0.7% +$1.05M 0.01% 800
2018
Q2
$146M Sell
506,658
-28,320
-5% -$7.82M 0.01% 820
2018
Q1
$134M Sell
534,978
-15,464
-3% -$3.94M 0.01% 834
2017
Q4
$131M Buy
550,442
+9,199
+2% +$2.23M 0.01% 873
2017
Q3
$120M Sell
541,243
-3,989
-0.7% -$898K 0.01% 887
2017
Q2
$123M Buy
545,232
+8,865
+2% +$1.93M 0.01% 850
2017
Q1
$107M Sell
536,367
-1,951
-0.4% -$376K 0.01% 911
2016
Q4
$98.1M Sell
538,318
-3,936
-0.7% -$671K 0.01% 920
2016
Q3
$88.8M Sell
542,254
-13,631
-2% -$2.07M 0.01% 942
2016
Q2
$79.5M Buy
555,885
+1,150
+0.2% +$164K 0.01% 952
2016
Q1
$75.8M Buy
554,735
+22,053
+4% +$2.9M 0.01% 959
2015
Q4
$73.9M Buy
532,682
+15,942
+3% +$2.21M 0.01% 966
2015
Q3
$69.4M Sell
516,740
-17,517
-3% -$2.52M 0.01% 986
2015
Q2
$80.5M Sell
534,257
-29,935
-5% -$4.28M 0.01% 972
2015
Q1
$76.3M Buy
564,192
+9,710
+2% +$1.2M 0.01% 1006
2014
Q4
$66.8M Sell
554,482
-5,923
-1% -$682K 0.01% 1061
2014
Q3
$63.5M Sell
560,405
-5,690
-1% -$674K 0.01% 1050
2014
Q2
$67.8M Buy
566,095
+8,162
+1% +$997K 0.01% 1064
2014
Q1
$71.5M Buy
557,933
+7,848
+1% +$1.01M 0.01% 1013
2013
Q4
$68M Sell
550,085
-20,789
-4% -$2.53M 0.01% 1039
2013
Q3
$67.1M Sell
570,874
-9,297
-2% -$1.1M 0.01% 1000
2013
Q2
$65.1M Buy
+580,171
New +$68.1M 0.01% 955

Other funds holding BIO